Literature DB >> 9045957

Growth characteristics in the initial stage of micrometastasis formation by bacterial LacZ gene-tagged rat prostatic adenocarcinoma cells.

K Kobayashi1, H Nakanishi, K Inada, Y Fujimitsu, T Yamachika, T Shirai, M Tatematsu.   

Abstract

A micrometastasis model was established using a rat differentiated prostatic adenocarcinoma, designated PLS30lZ, transfected with the lacZ gene encoding a bacterial beta-galactosidase. The morphology, tumorigenicity and metastatic ability of PLS30lZ were comparable to those of the parental cells. Micrometastatic foci could be specifically detected at the single cell level after X-Gal staining with a dissecting microscope. After intravenous injection, the number of X-Gal positive foci in the lung decreased progressively to a steady-state level (less than 1% of injected cells) by 4-7 days, while the size of persisting positive foci started to increase from 4 days after inoculation, as demonstrated by image analysis. X-Gal and BrdU double staining revealed that BrdU labeling indices of X-Gal-positive cells decreased transiently at the 2-day time point and increased again from 4 days after inoculation. Type IV collagen immunostaining showed the tumor cells to be surrounded by a basement membrane intravascularly at the time point when they started new growth. Electron microscopy confirmed that, 2 days post injection, most tumor cells were degenerative or dead, but on day 4, persisting tumor cells formed multicellular clumps in contact with the vascular basement membrane inside vessels. These results indicate that PLS30lZ cells begin to grow intravascularly depending upon the presence of a basement membrane before extravasation at the initial stage of micrometastasis formation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9045957      PMCID: PMC5921025          DOI: 10.1111/j.1349-7006.1996.tb03137.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  25 in total

Review 1.  Growth dominance of the metastatic cancer cell: cellular and molecular aspects.

Authors:  R S Kerbel
Journal:  Adv Cancer Res       Date:  1990       Impact factor: 6.242

2.  Tumor cell dissemination patterns and metastasis of murine mammary carcinoma.

Authors:  S F Juacaba; E Horak; J E Price; D Tarin
Journal:  Cancer Res       Date:  1989-02-01       Impact factor: 12.701

Review 3.  The role of natural killer cells in the control of tumor growth and metastasis.

Authors:  N Hanna
Journal:  Biochim Biophys Acta       Date:  1985

4.  Examination of enzyme-altered foci with gamma-glutamyl transpeptidase, aldehyde dehydrogenase, glucose-6-phosphate dehydrogenase, and other markers in methacrylate-embedded liver.

Authors:  T P Pretlow; R W Grane; P L Goehring; A S Lapinsky; T G Pretlow
Journal:  Lab Invest       Date:  1987-01       Impact factor: 5.662

Review 5.  Integrating with integrins.

Authors:  M A Schwartz; D E Ingber
Journal:  Mol Biol Cell       Date:  1994-04       Impact factor: 4.138

6.  Evaluation of a nude mouse tumor model using beta-galactosidase-expressing melanoma cells.

Authors:  T P Dooley; M Stamp-Cole; R J Ouding
Journal:  Lab Anim Sci       Date:  1993-02

Review 7.  The pathogenesis of cancer metastasis.

Authors:  G Poste; I J Fidler
Journal:  Nature       Date:  1980-01-10       Impact factor: 49.962

8.  Establishment and characterization of three androgen-independent, metastatic carcinoma cell lines from 3,2'-dimethyl-4-aminobiphenyl-induced prostatic tumors in F344 rats.

Authors:  H Nakanishi; S Takeuchi; K Kato; S Shimizu; K Kobayashi; M Tatematsu; T Shirai
Journal:  Jpn J Cancer Res       Date:  1996-12

9.  Cellular growth and survival are mediated by beta 1 integrins in normal human breast epithelium but not in breast carcinoma.

Authors:  A R Howlett; N Bailey; C Damsky; O W Petersen; M J Bissell
Journal:  J Cell Sci       Date:  1995-05       Impact factor: 5.285

10.  Receptor tyrosine kinase signaling required for integrin alpha v beta 5-directed cell motility but not adhesion on vitronectin.

Authors:  R L Klemke; M Yebra; E M Bayna; D A Cheresh
Journal:  J Cell Biol       Date:  1994-11       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.